News Search Results
Feb 26, 2026, 14:50 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
[Click here for information about joining the class action]Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with,
More news about: Pomerantz LLP
Feb 26, 2026, 12:50 ET Cerecin Announces Publication of Clinical Study Demonstrating Promising Results of CER-0001 (tricaprilin) for Rare Pediatric Epilepsy
(DEE).DENVER, Feb. 26, 2026 /PRNewswire/ -- Cerecin Inc., a clinical-stage biotechnology company developing metabolic drugs for neurological disorders, today announced the publication of a Phase 1/2a clinical study evaluating the investigational
More news about: Cerecin Inc.
Feb 26, 2026, 12:41 ET Greenberg Traurig Prevails for Investor in Oil Terminal Ownership Breach of Contract Suit
resources, financial institutions, health care, hedge funds, hospitality, infrastructure, insurance, media, medical devices, pharmaceutical and biotechnology, real estate, retail, sports, technology and software, telecommunications, transportation, and video games and esports.About Greenberg
More news about: Greenberg Traurig, LLP
Feb 26, 2026, 11:00 ET ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
reference laboratory in the U.S., today announced the launch of a new Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners. The Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating next generation
More news about: ARUP Laboratories
Feb 26, 2026, 11:00 ET uniQure N.V. Stock Alert: QURE Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses
investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases.
More news about: Robbins LLP
Feb 26, 2026, 10:57 ET Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.
Feb 26, 2026, 10:30 ET Inovio Pharmaceuticals, Inc. Stock Alert: INO Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses
purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with,
More news about: Robbins LLP
Feb 26, 2026, 10:00 ET Transformative Biotech Names Mark Kelleher, PhD as Executive VP of R&D
reinforcing its commitment to shaping the future of molecular diagnostics.About Transformative Biotech Transformative Biotech is a biotechnology company focused on deploying rapid, highly accurate, and robust, direct-to-PCR technologies with the power to transform molecular testing for infectious
More news about: Transformative Biotech, LLC
Feb 26, 2026, 10:00 ET Monod Bio Announces Appointment of Robert J. Bujarski to Board of Directors
Health Industry Distributors Association (HIDA) Educational Foundation.About Monod BioMonod Bio is a Seattle-based biotechnology company and a spinout from the David Baker Lab at the University of Washington's Institute for Protein Design. The company uses AI-powered de novo
More news about: Monod Bio
Feb 26, 2026, 08:24 ET Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer
life sciences and diagnostics innovator. Mr. Beauvalot's roles included vice president and head of business development and strategy for Danaher's biotechnology and genomics business areas. Mr. Beauvalot also served as vice president of strategy and corporate development and vice president of global business
More news about: Quest Diagnostics
Feb 26, 2026, 08:15 ET genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model
(Belgium), a pioneer in Fc-engineering and FcRn biology; Innate Pharma (France), a leader in natural killer cell-based immunotherapies; and Vir Biotechnology (USA), focused on the development of immunotherapies; among other members. The group collaborated with VIB-Ghent University (Belgium), a leading
More news about: genOway
Feb 26, 2026, 08:00 ET SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union
Feb. 26, 2026 /PRNewswire/ -- SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been selected for Phase 1 of a next-generation vaccine development initiative managed by the European Health and Digital
More news about: SK bioscience
Feb 26, 2026, 07:30 ET Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Feb 26, 2026, 07:00 ET HotSpot Therapeutics to Present Preclinical Data from Small Molecule IRF5 Inhibitor Program at 15th European Lupus Meeting
BOSTON, Feb. 26, 2026 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target natural regulatory pockets, today announced it
More news about: HotSpot Therapeutics
Feb 26, 2026, 07:00 ET Matricelf Ltd. (TASE: MTLF) Reports 2025 Milestones and Outlines 2026 Strategic Roadmap Toward First-in-Human Spinal Cord Implantation
NESS ZIONA, Israel, Feb. 26, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a biotechnology company developing personalized regenerative therapies for spinal cord injury, today issued a shareholder update summarizing its 2025 achievements
More news about: Matricelf Ltd.
Feb 26, 2026, 06:30 ET Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced financial results for the
More news about: Immunic, Inc.
Feb 26, 2026, 06:30 ET Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Feb 26, 2026, 05:40 ET CJ BIO Publishes Clinical Study on BiomeNrich™ POST SZ075, a Postbiotic Ingredient Demonstrating Skin Improvement Benefits
density.Dual-Action Efficacy of BiomeNrich™ POST SZ075 for Skin Health A clinical study (n=111, 12 weeks, 500 mg/day) published in Food Science and Biotechnology (2025) confirms the dual functionality of BiomeNrich™ POST SZ075 in combating UV-induced wrinkles and enhancing hydration.I. Skin wrinkle
More news about: CJ CheilJedang
Feb 26, 2026, 03:15 ET genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model
(Belgium), a pioneer in Fc-engineering and FcRn biology; Innate Pharma (France), a leader in natural killer cell-based immunotherapies; and Vir Biotechnology (USA), focused on the development of immunotherapies; among other members. The group collaborated with VIB-Ghent University (Belgium), a leading
More news about: genOway
Feb 26, 2026, 03:15 ET genOway: Revolution der Vorhersage von Antikörpertherapien beim Menschen mit einem einzigartigen Mausmodell
FcRn-Biologie, Innate Pharma (Frankreich), ein führendes Unternehmen im Bereich der auf natürlichen Killerzellen basierenden Immuntherapien, und Vir Biotechnology (USA), das sich auf die Entwicklung von Immuntherapien konzentriert. Die Gruppe arbeitete mit der VIB-Ghent University (Belgien), einem führenden
More news about: genOway
Feb 26, 2026, 03:15 ET genOway:Revolucionando la predicción de terapias con anticuerpos en humanos con un modelo de ratón único
(Bélgica), pionera en ingeniería de Fc y biología de FcRn; Innate Pharma (Francia), líder en inmunoterapias basadas en células asesinas naturales; y Vir Biotechnology (Estados Unidos) enfocada en el desarrollo de inmunoterapias; entre otros miembros. El grupo colaboró con VIB-Ghent University (Bélgica), un instituto
More news about: genOway
Feb 26, 2026, 03:15 ET genOway : révolutionner la prédiction des thérapies à base d'anticorps chez l'humain grâce à un modèle murin unique
l'ingénierie Fc et de la biologie FcRn ; Innate Pharma (France), un leader des immunothérapies basées sur les cellules tueuses naturelles ; et Vir Biotechnology (États-Unis), spécialisé dans le développement d'immunothérapies, entre autres membres. Le groupe a collaboré avec le VIB-Gand (Belgique), un institut
More news about: genOway
Feb 26, 2026, 03:08 ET BPC Instruments reports results for 2025
AB (publ)BPC Instruments is a Swedish technology company developing analytical instruments for renewable bioenergy and environmental biotechnology, including biogas and biodegradability testing. The systems enable advanced testing with higher accuracy and consistency, while reducing the time
More news about: BPC Instruments AB
Feb 26, 2026, 00:00 ET New book 'The Oceans and Deserts Stock Exchange' proposes a market-driven solution to defeat climate change without economic collapse
"Tackling the Major Challenges of Our Times and Building The Selfless Economy." He graduated from The Johns Hopkins University with a master's in biotechnology enterprise and Entrepreneurship, an MBA from Michigan State University, and a bachelor's from the University of Illinois-Springfield. Mr. Matthew
More news about: Archway Publishing
Feb 25, 2026, 21:00 ET Argo Biopharma to Present Positive Phase II Interim Results of siRNA Therapeutic BW-20805 for HAE at the 2026 AAAAI Annual Meeting
HAE attacks with a significant and longer-lasting therapeutic effect.About Argo BiopharmaArgo Biopharma is a clinical-stage biotechnology company committed to developing next-generation RNAi therapeutics to provide better treatment options for patients worldwide. The company has established
More news about: Argo Biopharmaceutical Co., Ltd